Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
Clinical trial NCT07432295 · RECRUITING
Trial details
- NCT number
- NCT07432295
- Sponsor
- I-Mab Biopharma US Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-11
- Primary completion
- 2030-03-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.